News

News Releases

Recent news releases

Month Year

Month Year

Investor Alerts

Jun 10, 2026

Apotex Health Corp. files final prospectus and announces pricing of upsized initial public offering
Jun 9, 2026

Apotex Health Corp. upsizes its initial public offering
Jun 3, 2026

Apotex launches sitagliptin tablets and sitagliptin and metformin hydrochloride tablets, eligible for 180-day shared exclusivity
Jun 1, 2026

Apotex Health Corp. launches its initial public offering
May 28, 2026

APOTEX HEALTH CORP. FILES PRELIMINARY PROSPECTUS FOR INITIAL PUBLIC OFFERING
May 26, 2026

Apotex expands ophthalmic portfolio with Health Canada approval of IHEEZO™
May 14, 2026

Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada
May 1, 2026

Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalent of Ozempic®
Apr 23, 2026

Apotex Announces Strategic Transaction with Cumberland Pharmaceuticals to Integrate their U.S. Branded Businesses
Apr 7, 2026

Apotex Strengthens Osteoporosis Care in Canada with Health Canada's Approval of DENOZA™, a Denosumab Biosimilar
Mar 30, 2026

Apotex announces leadership changes
Mar 25, 2026

Apotex Expands Canadian Ophthalmology Portfolio with Health Canada's Approval of CLOBIVIS™ (Clobetasol Propionate Ophthalmic Suspension, 0.05%)
Feb 5, 2026

Apotex licenses exclusive Canadian rights to testosterone replacement therapy Nebido® from Grünenthal
Oct 23, 2025

Apotex Receives Health Canada Approval for LOQTORZI® -- The First and Only Immuno-Therapy for Recurrent Unresectable or Metastatic Nasopharyngeal Cancer
Oct 7, 2025

Apotex Strengthens Commitment to Women's Health with Exclusive Canadian Rights to "Linzagolix" for Uterine Fibroid Treatment
May 20, 2025

Apotex publishes 2024 Sustainability Report, highlighting progress and achievements in environmentally sustainable manufacturing, responsible business practices, and social impact
May 13, 2025

Apotex announces grant to Foundation for Mother and Child Health to promote maternal health with CAD $100,000 in annual funding
May 13, 2025

Apotex announces $100,000 in annual funding to advance maternal and infant health in Mexico

Show per page